MIAMI–(BUSINESS WIRE)–Bio-Tissue, a business unit of TissueTech, Inc., today announced the
global online availability of its newest product Cliradex Light advanced
foaming eyelid cleanser on its newly redesigned website, www.cliradex.com.
International purchases may be directed to Amazon Marketplace.
Cliradex Light – which was launched last year and quickly realized high
consumer and physician office demand – is ideal for preventative eyelid
care, everyday ocular hygiene and mild-to-moderate ocular irritation.
“Cliradex Light occupies a unique position in the ocular surface disease
spectrum as an at-home therapy for patients suffering from ocular
irritation due to mild blepharitis,” said Thomas Daniells, Chief
Commercial Officer at Bio-Tissue.
The global Cliradex Light product launch, which coincides with the
website relaunch, will enable a more intuitive user experience focused
on the theme of “Find Your Escape from Ocular Irritation” to highlight
the product’s importance in a daily eye care regimen.
The new site also features:
- An integrated branding experience with our packaging for consistency.
Product placement for easy access to important information.
- Our money back guarantee, which is also given prominent visibility.
- A new blog with a Facebook newsfeed.
Cliradex products are hygienic products designed to clean the eyelids
and surrounding skin to alleviate and prevent symptoms of blepharitis
and other lid margin diseases. Blepharitis is primarily caused by eyelid
Bacteria and microbes feed on oils and create waste; damaging the ocular
environment. If left untreated, these factors can also lead to more
severe diseases such as dry eye.
Cliradex products are natural, preservative-free lid, lash and facial
cleansers formulated with 4-Terpineol, a molecule found in tea tree oil.
Cliradex Light works best for mild-to-moderate blepharitis, and is also
recommended for maintenance use after Cliradex towelettes are
discontinued in the treatment of moderate-to-severe blepharitis and for
a business unit of TissueTech, Inc., develops and markets regenerative
therapies that are advancing the standard of care for treating the
ocular surface. The company’s products include: Prokera®, a FDA-cleared
biologic corneal bandage device, comprised of cryopreserved amniotic
tissue, for early intervention of ocular surface disease and conditions;
AmnioGraft®, a surgical graft for repairing and restoring a healthy
ocular surface; and Cliradex® wipes and foam cleanser, which are a
natural, preservative-free lid, lash and facial cleanser formulated with
4-Terpineol (T4O). Bio-Tissue’s products are backed by years of
scientific research and clinical studies.